NEW YORK(GenomeWeb) – NanoString Technologies said after the close of the market on Monday that the US Food and Drug Administration cleared a labeling update for the company's Prosigna Breast Cancer Gene Signature Assay.
Registering provides access to this and other free content.
Already have an account?Login Now.
Researchers test gene therapy targeting a different cancer protein in a new trial, the New York Times reports.
Pennsylvania State University researchers found that salivary microRNAs could predict which kids would have longer concussion symptoms, according to NPR.
The Associated Press reports Alex Azar, the new Department of Health and Human Services secretary nominee, made millions of dollars as a pharmaceutical executive.
In PNAS this week: immune profiling of breast cancer, transposable element patterns in rice, and more.